FDA warning letter to
QuVa Pharma, Inc.
Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.
QuVa Pharma, Inc.'s FDA history
Recalls in the last 12 months
| Jul 15 | Class II | QuVa Pharma, Inc. Drug |
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46. Failed Impurities/Degradation Specifications |